Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Effects of menstrual disorders and dysmenorrhea on cardiovascular disease: a Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 02/26/2024 - 12:31
  • Read more about Effects of menstrual disorders and dysmenorrhea on cardiovascular disease: a Mendelian randomization study

The Impact of Testosterone on Alzheimer's Disease Are Mediated by Lipid Metabolism and Obesity: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 02/26/2024 - 12:11
  • Read more about The Impact of Testosterone on Alzheimer's Disease Are Mediated by Lipid Metabolism and Obesity: A Mendelian Randomization Study

Fruit Intake and Alzheimer's Disease: Results from Mendelian Randomization

Submitted by Frida Mäkelä on Mon, 02/26/2024 - 12:07
  • Read more about Fruit Intake and Alzheimer's Disease: Results from Mendelian Randomization

No causal association between atopic dermatitis and COVID-19 outcomes: A Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 02/26/2024 - 12:01
  • Read more about No causal association between atopic dermatitis and COVID-19 outcomes: A Mendelian randomization study

Associations between gut microbiota and three prostate diseases: a bidirectional two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 02/26/2024 - 11:58
  • Read more about Associations between gut microbiota and three prostate diseases: a bidirectional two-sample Mendelian randomization study

Mineral Metabolism and Polycystic Ovary Syndrome and Metabolic Risk Factors: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 02/26/2024 - 11:56
  • Read more about Mineral Metabolism and Polycystic Ovary Syndrome and Metabolic Risk Factors: A Mendelian Randomization Study

The Causal Association Between Medication Intake and Increased Risk of Psoriasis

Submitted by Frida Mäkelä on Mon, 02/26/2024 - 11:52
  • Read more about The Causal Association Between Medication Intake and Increased Risk of Psoriasis

Identification of systemic biomarkers and potential drug targets for age-related macular degeneration

Submitted by Frida Mäkelä on Fri, 02/16/2024 - 14:56
  • Read more about Identification of systemic biomarkers and potential drug targets for age-related macular degeneration

Genetically proxied phosphodiesterase type 5 (PDE5) inhibition and risk of dementia: a drug target Mendelian randomisation study

Submitted by Frida Mäkelä on Fri, 02/16/2024 - 10:05
  • Read more about Genetically proxied phosphodiesterase type 5 (PDE5) inhibition and risk of dementia: a drug target Mendelian randomisation study

Quantifying variant contributions in cystic kidney disease using national-scale whole genome sequencing

Submitted by Frida Mäkelä on Fri, 02/16/2024 - 09:57
  • Read more about Quantifying variant contributions in cystic kidney disease using national-scale whole genome sequencing

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 347
  • Page 348
  • Page 349
  • Page 350
  • Current page 351
  • Page 352
  • Page 353
  • Page 354
  • Page 355
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement